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Abstract 
Genomic imprinting is essential for normal placental and fetal growth. One theory to explain the 
evolution of imprinting is the kinship theory (KT), which predicts that genes that are paternally 
expressed will promote fetal growth, whereas maternally expressed genes will suppress growth. 
We investigated the expression of imprinted genes using microarray measurements of expression 
in term placentae. Correlations between birthweight and the expression levels of imprinted genes 
were more significant than for non-imprinted genes, but did not tend to be positive for paternally 
expressed genes and negative for maternally expressed genes. Imprinted genes were more 
dysregulated in preeclampsia (a disorder associated with placental insufficiency) than randomly-
selected genes, and we observed an excess of patterns of dysregulation in preeclampsia that 
would be expected to reduce nutrient allocation to the fetus, given the predictions of the KT. 
However, we found no evidence of coordinated regulation among these imprinted genes. A few 
imprinted genes have previously been shown to be associated with fetal growth and 
preeclampsia, and our results indicate that this is true for a broader set of imprinted genes. 
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Introduction 
Genomic imprinting is a phenomenon where the expression of an allele depends on whether it 
was inherited from the mother or the father. Many known imprinted genes in humans are 
expressed in the placenta and are essential for its normal function [1,2]. One theory to explain 
imprinting is the parental conflict theory, or kinship theory (KT), which proposes that there is a 
potential genetic conflict of interest between maternally and paternally inherited alleles [3,4]. 
Because of the possibility of multiple paternity, maternally inherited alleles are more likely to be 
related to alleles found in siblings who share a mother than are paternally inherited alleles. 
Therefore, paternally expressed genes (PEGs) are expected to promote the growth of the fetus, 
whereas maternally expressed genes (MEGs) are expected to constrain fetal growth to conserve 
resources so that they can be allocated more equally among a fetus and its siblings [1,5]. 
The expression levels of some imprinted genes have been correlated with fetal growth [6] 
and pregnancy complications associated with placental insufficiency such as preeclampsia (PE) 
and intrauterine growth restriction (IUGR) [5,7,8]. However, no study has systematically 
compared the expression of imprinted and non-imprinted genes in terms of associations with 
birthweight or pregnancy complications. Since the KT posits that imprinted genes are involved in 
nutrient allocation, this theory predicts that the placental expression of imprinted genes will be 
more strongly correlated with birthweight than non-imprinted genes. Imprinted genes are also 
expected to be dysregulated more than non-imprinted genes in PE and IUGR placentae, where 
nutrient delivery to the fetus is thought to be impaired. Furthermore, the KT predicts that 
increased expression of MEGs and decreased expression of PEGs will limit maternal investment 
in the fetus, whereas the opposite patterns will promote investment. The expression of imprinted 
genes might drive fetal growth and/or contribute to placental pathology, but imprinted genes 
might also take part in compensation for poor fetal growth and/or placental pathology, in which 
case the opposite expression patterns would be observed (Fig. 1). Furthermore, the expression of 
PEGs might counterbalance the expression of MEGs and vice versa, in which case no correlation 
between gene expression and birthweight or pathology would be observed (Fig. 1). 
We used microarray measurements of gene expression in term placentae to test multiple 
predictions that follow from the KT. We tested (1) whether imprinted genes are more strongly 
correlated with birthweight than non-imprinted genes, (2) whether imprinted genes are more 
dysregulated in PE and IUGR than non-imprinted genes, and (3) whether there is an excess of 
patterns of expression expected to drive fetal growth/ contribute to PE, or compensate for poor 
placental growth/placental insufficiency in PE (Fig. 1). We also hypothesized that genes showing 
the same patterns (i.e., expected to limit investment according to the KT or expected to promote 
investment) would be regulated by the same transcription factors. Therefore, we also tested (4) 
whether there is evidence of coordinated regulation among genes showing limiting patterns 
according to the KT, and among genes showing promoting patterns, but not between these two 
sets, e.g., we would not expect a transcription factor in a pathway promoting maternal investment 
to downregulate some maternally expressed genes and upregulate others. 
Material and methods 
A list of 120 unique genes imprinted in humans was compiled [9–12] (Supplementary Tables 1 
and 2). We obtained expression data for 19882 genes in 157 placental samples [13], all of which 
were used for analyses of birthweight. However, since PE and IUGR have diverse 
pathophysiology, we reduced heterogeneity by restricting our analyses to PE and IUGR samples 
from a single cluster (cluster 2) defined by clustering of gene expression; this cluster exhibits 
histopathological features of insufficient placental development [13]. Hence, the sample size was 
117 for analyses of PE and IUGR (Table 1). We removed genes annotated as “not detected” in 
the placenta by Protein Atlas [14], leaving 14986 genes, including 28 MEGs and 33 PEGs 
(Supplementary Table 3). Clinical data included gestational age at delivery, occurrence of PE, 
occurrence of IUGR, birthweight (correcting for gestational age and sex) and offspring sex [13].  
For each gene, we performed a general linear model with gene expression as the 
dependent variable and terms for birthweight (or occurrence of IUGR), PE, fetal sex, and 
gestational age. This yielded, for each gene, F-statistics for the effects of birthweight (or IUGR) 
and preeclampsia on gene expression (Supplementary Table 3). As measures of effect size, we 
obtained the slope of the regression of gene expression on birthweight or the fold change in gene 
expression between IUGR or PE and controls.  
We tested whether the significance and effect size of imprinted genes were greater than 
would be expected for random genes. We selected genes at random from the complete set, such 
that the number of genes in the random sample was the same as the number of imprinted genes. 
We repeated this sampling 10000 times to calculate null distributions for the F-statistic and effect 
size, to which we compared the values for imprinted genes.  
To identify sets of imprinted genes showing an investment-limiting or -promoting pattern 
for PE or IUGR, we selected imprinted genes with significant effects (alpha = 0.05). PEGs with 
increased expression and MEGs with decreased expression in PE or IUGR were categorized as 
promoting investment whereas those showing the opposite pattern were categorized as limiting. 
To test for coordinated regulation among genes showing the same pattern, we calculated the 
proportion of variation explained by the first principal component within sets of genes and 
assessed whether this was greater within sets than between sets. To achieve this, we combined 
the limiting and promoting genes, divided them into two sets at random, and calculated the 
proportion of variation explained by the first principal component within each. The actual 
proportion of variation explained in each of the sets was compared with the null distribution 
from 10000 randomizations. All analyses were performed in SAS, Version 9.4. 
Results 
The correlation between birthweight and the expression levels of imprinted genes was greater 
than that for randomly-selected genes (P = 0.011; Supplementary Figure 1). However, the 
directions of the correlations between imprinted genes and birthweight did not deviate from 
random, i.e., there was not an excess of the expected pattern (positive correlations between PEGs 
and birthweight, and negative correlations between MEGs and birthweight) or the reverse pattern 
(P = 0.21). If the expression of PEGs were counterbalancing the expression of MEGs or vice 
versa, we would expect an excess of positive correlations among PEGs and MEGs, but this was 
not observed (Supplementary Table 4). 
Imprinted genes were more dysregulated in PE than randomly-selected genes (P = 0.032), 
but were not more dysregulated in IUGR than expected due to chance (P = 0.13; Supplementary 
Figure 1). The direction of effects was consistent with imprinted genes limiting investment in 
pregnancies complicated by PE (i.e., PEGs downregulated and MEGs upregulated in PE; P = 
0.021; Table 2), with a similar but marginally non-significant pattern for IUGR (P = 0.082; Table 
2).  
We tested for coordinated regulation among sets of genes showing limiting or promoting 
patterns, as predicted by the KT (Supplementary Table 3). For PE, the correlation in expression 
levels was not greater within promoting genes (P = 0.28) or within limiting genes (P = 0.50) than 
between these two sets of genes. Similarly, there was no evidence of increased co-regulation in 
promoting or limiting genes (P = 0.84 and P = 0.22, respectively) categorized by dysregulation in 
IUGR. 
Discussion  
In general, imprinted genes had stronger correlations with birthweight and were more 
differentially expressed in PE than randomly-selected genes. However, the directions of the 
correlations between birthweight and gene expression did not show an excess of patterns 
predicted to drive fetal growth according to the KT, and the pattern of up- and downregulation in 
IUGR was not significantly different than that of random genes. 
In PE, the pattern of up- and downregulation was consistent with imprinted genes 
limiting maternal investment in complicated pregnancies (i.e., PEGs downregulated and MEGs 
upregulated in PE). A potential explanation for this result is that imprinted genes are contributing 
to placental pathology. Imprinted genes are often coordinately regulated [15], and if some 
imprinted genes were contributing to placental pathology, it would not be expected that each 
gene would be independently regulated; some genes would be regulated by the same 
transcription factors. However, we found no evidence of coordinated regulation among genes 
predicted to limit maternal investment based on the KT. This suggests that imprinted genes 
predicted by the KT to have similar effects in pathological pregnancies are not more likely to be 
part of a common pathway. Alternatively, some of these genes may not play roles in limiting or 
promoting maternal investment as predicted by the KT, potentially because the KT does not 
explain the imprinting of these genes.  
Our study examined gene expression at the end of pregnancy, whereas nutrient allocation 
is determined much earlier. However, this limitation does not explain why imprinted genes 
showed stronger correlations with birthweight and greater dysregulation in PE than expected due 
to chance. While some imprinted genes have previously been shown to play important roles in 
placental development and function [16–18], our results suggest that this is true for some other, 
less-studied imprinted genes. Further investigation into the expression patterns of imprinted 
genes will improve our understanding of the mechanisms underlying poor fetal growth and 
severe pregnancy complications. 
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Table 1. Gestational age at delivery (weeks). 219 
 PE+IUGR PE only IUGR only Control 
N 19 31 4 63 
Mean (SD) 30.8 (2.0) 31.9 (3.5) 32.6 (3.2) 34.9 (4.9) 
Range 27.0 – 34.1 26.9 – 39.3 29.4 – 37.1 25.9 – 41.1 
 220 
 221 
Table 2. Statistical significance and effects of birthweight, preeclampsia, and intrauterine growth 222 
restriction (means ± SE; * = imprinted genes significantly different from all genes at alpha = 223 
0.05). 224 
 Parameter All genes  
(N = 14986) 
Imprinted genes  
(N = 61) 
Birthweight (continuous) F-statistic 3.88 ± 0.04 5.61 ± 0.88* 
 Effect size1 1.01 ± 0.00 1.00 ± 0.00 
Preeclampsia F-statistic 7.36 ± 0.10 10.56 ± 1.78* 
 Effect size1 1.00 ± 0.00 1.03 ± 0.02* 
Intrauterine growth 
restriction 
F-statistic 1.86 ± 0.02 2.24 ± 0.35 
 Effect size1 0.99 ± 0.00 1.01 ± 0.01 
 225 
1For all genes, a value less than 1 indicates a negative correlation between gene expression and 226 
birthweight, reduced expression in PE compared with controls, or reduced expression in IUGR 227 
compared with controls, whereas values greater than 1 indicate the opposite patterns. For 228 
imprinted genes, values less than 1 indicate patterns expected to promote investment in response 229 
to low birthweight/pathology, while values greater than 1 indicate patterns expected to drive fetal 230 
growth or contribute to PE/IUGR. More detailed description is provided in Supplementary Table 231 
3.  232 
Figure 1. Patterns of gene expression for individual imprinted genes, and interpretations under 233 
the KT. 234 

